Muscarinic receptors and ligands in cancer

被引:113
|
作者
Shah, Nirish
Khurana, Sandeep
Cheng, Kunrong
Raufman, Jean-Pierre [1 ]
机构
[1] Univ Maryland, Div Gastroenterol & Hepatol, VA Maryland Hlth Care Syst, Program Oncol,Greenebaum Canc Ctr,Sch Med, Baltimore, MD 21201 USA
来源
基金
美国国家卫生研究院;
关键词
tumor genesis; nonneuronal; cholinergic signaling; acetylcholine; bile acids; CELL LUNG-CARCINOMA; NONNEURONAL CHOLINERGIC SYSTEM; POLYSPECIFIC CATION TRANSPORTERS; INTESTINAL ION-TRANSPORT; NITRIC-OXIDE SYNTHASE; GUINEA-PIG ILEUM; COLON-CANCER; SMOOTH-MUSCLE; ACETYLCHOLINE-RECEPTORS; INDUCED PROLIFERATION;
D O I
10.1152/ajpcell.00514.2008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Shah N, Khurana S, Cheng K, Raufman JP. Muscarinic receptors and ligands in cancer. Am J Physiol Cell Physiol 296: C221-C232, 2009. First published November 26, 2008; doi:10.1152/ajpcell.00514.2008.-Emerging evidence indicates that muscarinic receptors and ligands play key roles in regulating cellular proliferation and cancer progression. Both neuronal and nonneuronal acetylcholine production results in neurocrine, paracrine, and autocrine promotion of cell proliferation, apoptosis, migration, and other features critical for cancer cell survival and spread. The present review comprises a focused critical analysis of evidence supporting the role of muscarinic receptors and ligands in cancer. Criteria are proposed to validate the biological importance of muscarinic receptor expression, activation, and postreceptor signaling. Likewise, criteria are proposed to validate the role of nonneuronal acetylcholine production in cancer. Dissecting cellular mechanisms necessary for muscarinic receptor activation as well as those needed for acetylcholine production and release will identify multiple novel targets for cancer therapy.
引用
收藏
页码:C221 / C232
页数:12
相关论文
共 50 条
  • [1] CENTRAL MUSCARINIC LIGANDS AND RECEPTORS
    BAKER, R
    SAUNDERS, J
    [J]. ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1989, 24 : 31 - 40
  • [2] Allosterism at muscarinic receptors: Ligands and mechanisms
    Birdsall, NJM
    Lazareno, S
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) : 523 - 543
  • [3] THE MODES OF BINDING OF LIGANDS TO CARDIAC MUSCARINIC RECEPTORS
    BIRDSALL, NJM
    CHAN, SC
    EVELEIGH, P
    HULME, EC
    MILLER, KW
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, : 31 - 34
  • [4] Muscarinic Receptors Associated with Cancer
    Calaf, Gloria M.
    Crispin, Leodan A.
    Munoz, Juan P.
    Aguayo, Francisco
    Bleak, Tammy C.
    [J]. CANCERS, 2022, 14 (09)
  • [5] Evidence for the presence of two sites for classical ligands on muscarinic receptors
    Tucek, S
    Jakubik, J
    Bacakova, L
    ElFakahany, EE
    [J]. LIFE SCIENCES, 1997, 60 (13-14) : 24 - 24
  • [6] INTERACTION OF DEGLYCOSYLATED MUSCARINIC RECEPTORS WITH LIGANDS AND G-PROTEINS
    OHARA, K
    UCHIYAMA, H
    OHARA, K
    HAGA, T
    ICHIYAMA, A
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 189 (06): : 341 - 346
  • [7] SYNTHESIS AND MUSCARINIC RECEPTORS AFFINITY OF A SERIES OF ANTAGONIST BIVALENT LIGANDS
    PIERGENTILI, A
    QUAGLIA, W
    TAYEBATI, SK
    PAPARELLI, F
    MALMUSI, L
    BRASILI, L
    [J]. FARMACO, 1994, 49 (02): : 83 - 87
  • [8] AFFINITY LIGANDS AND RELATED AGENTS FOR BRAIN MUSCARINIC AND NICOTINIC CHOLINERGIC RECEPTORS
    ABOOD, LG
    SARASWATI, M
    LERNERMARMAROSH, N
    HASHMI, M
    [J]. BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) : 2143 - 2148
  • [9] Design, synthesis, and biological evaluation of orthosteric ligands for the muscarinic acetylcholine receptors
    Millard, Marlon
    Kilian, Jonas
    Ozenil, Marius
    Mogeritsch, Mariella
    Maisetschlaeger, Verena
    Stellnberger, Sarah
    Hacker, Marcus
    Langer, Thierry
    Pichler, Verena
    [J]. NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S38 - S39
  • [10] ANALYSIS OF CARDIAC MUSCARINIC RECEPTORS RECOGNIZED SELECTIVELY BY NONQUATERNARY BUT NOT BY QUATERNARY LIGANDS
    BROWN, JH
    GOLDSTEIN, D
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1986, 238 (02): : 580 - 586